List of Tables
Table 1. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Product Type & Application
Table 12. Global Key Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2020-2025) & (K Units)
Table 18. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2020-2025)
Table 19. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2026-2031) & (K Units)
Table 20. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2026-2031)
Table 21. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2020-2025)
Table 23. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2026-2031)
Table 25. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2020-2025) & (K Units)
Table 27. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2026-2031) & (K Units)
Table 28. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2020-2025) & (K Units)
Table 32. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2026-2031) & (K Units)
Table 33. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Type (2020-2025)
Table 51. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Type (2026-2031)
Table 52. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2020-2025)
Table 53. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2026-2031)
Table 54. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2020-2025)
Table 57. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2026-2031)
Table 58. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Type (2020-2025)
Table 59. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Type (2026-2031)
Table 60. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Application (2020-2025)
Table 61. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Application (2026-2031)
Table 62. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2020-2025)
Table 63. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2026-2031)
Table 64. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2020-2025)
Table 67. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2026-2031)
Table 68. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Application (2020-2025)
Table 69. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Application (2026-2031)
Table 70. CNADC Company Information
Table 71. CNADC Description and Business Overview
Table 72. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 74. CNADC Recent Developments/Updates
Table 75. Boehringer-Ingelheim Company Information
Table 76. Boehringer-Ingelheim Description and Business Overview
Table 77. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 79. Boehringer-Ingelheim Recent Developments/Updates
Table 80. MSD Animal Health Company Information
Table 81. MSD Animal Health Description and Business Overview
Table 82. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 84. MSD Animal Health Recent Developments/Updates
Table 85. Sinopharm Company Information
Table 86. Sinopharm Description and Business Overview
Table 87. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 89. Sinopharm Recent Developments/Updates
Table 90. Ceva Company Information
Table 91. Ceva Description and Business Overview
Table 92. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 94. Ceva Recent Developments/Updates
Table 95. Chengdu Tianbang Biological Products Co., Ltd. Company Information
Table 96. Chengdu Tianbang Biological Products Co., Ltd. Description and Business Overview
Table 97. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 99. Chengdu Tianbang Biological Products Co., Ltd. Recent Developments/Updates
Table 100. Tianjin Ruipu Biological Technology Co., Ltd. Company Information
Table 101. Tianjin Ruipu Biological Technology Co., Ltd. Description and Business Overview
Table 102. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 104. Tianjin Ruipu Biological Technology Co., Ltd. Recent Developments/Updates
Table 105. Qilu Animal Health Company Information
Table 106. Qilu Animal Health Description and Business Overview
Table 107. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 109. Qilu Animal Health Recent Developments/Updates
Table 110. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Company Information
Table 111. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Description and Business Overview
Table 112. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 114. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Developments/Updates
Table 115. CAVAC Company Information
Table 116. CAVAC Description and Business Overview
Table 117. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 119. CAVAC Recent Developments/Updates
Table 120. Komipharm Company Information
Table 121. Komipharm Description and Business Overview
Table 122. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 124. Komipharm Recent Developments/Updates
Table 125. Agrovet Company Information
Table 126. Agrovet Description and Business Overview
Table 127. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 129. Agrovet Recent Developments/Updates
Table 130. Bioveta Company Information
Table 131. Bioveta Description and Business Overview
Table 132. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 134. Bioveta Recent Developments/Updates
Table 135. Jinyu Bio-Technology Company Information
Table 136. Jinyu Bio-Technology Description and Business Overview
Table 137. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 139. Jinyu Bio-Technology Recent Developments/Updates
Table 140. Phibro Animal Health Company Information
Table 141. Phibro Animal Health Description and Business Overview
Table 142. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 144. Phibro Animal Health Recent Developments/Updates
Table 145. Tiankang Company Information
Table 146. Tiankang Description and Business Overview
Table 147. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 149. Tiankang Recent Developments/Updates
Table 150. Zoetis Company Information
Table 151. Zoetis Description and Business Overview
Table 152. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 154. Zoetis Recent Developments/Updates
Table 155. Guangdong Yongshun Biological Pharmaceutical Co Ltd Company Information
Table 156. Guangdong Yongshun Biological Pharmaceutical Co Ltd Description and Business Overview
Table 157. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 159. Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Developments/Updates
Table 160. Plec Bioengineering Co., Ltd. Company Information
Table 161. Plec Bioengineering Co., Ltd. Description and Business Overview
Table 162. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 164. Plec Bioengineering Co., Ltd. Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List
Table 168. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers List
Table 169. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Trends
Table 170. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Drivers
Table 171. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Challenges
Table 172. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
Figure 2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Type: 2024 & 2031
Figure 4. Live Vaccine Product Picture
Figure 5. Inactivated Vaccine Product Picture
Figure 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Application: 2024 & 2031
Figure 8. Government Tender
Figure 9. Marketing
Figure 10. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size (2020-2031) & (US$ Million)
Figure 12. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (2020-2031) & (K Units)
Figure 13. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price (US$/Unit) & (2020-2031)
Figure 14. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Report Years Considered
Figure 15. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Manufacturers in 2024
Figure 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players: Market Share by Revenue in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) in 2024
Figure 18. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2020-2031)
Figure 21. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2020-2031)
Figure 22. United States Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2020-2031)
Figure 25. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2020-2031)
Figure 26. Germany Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2020-2031)
Figure 33. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2020-2031)
Figure 43. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Type (2020-2031)
Figure 53. Global Revenue Market Share of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Type (2020-2031)
Figure 54. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application (2020-2031)
Figure 56. Global Revenue Market Share of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application (2020-2031)
Figure 57. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Application (2020-2031)
Figure 58. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
